Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Little Optics was a pioneer in the development of micro-optical components, specifically micro-ring resonators and high-index contrast silica waveguides known as Hydex. While the company initially targeted the telecommunications sector, its technology became a foundational platform for high-sensitivity biosensing and chemical detection. Following its acquisition by ICx Technologies, the Little Optics platform was integrated into advanced biodefense and diagnostic systems designed to detect biological and chemical threats. The company's innovations in silicon photonics continue to influence modern diagnostic platforms that utilize optical resonators for label-free molecular detection.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Little Optics.